| Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial BK Puri, BR Leavitt, MR Hayden, CA Ross, A Rosenblatt, JT Greenamyre, ... Neurology 65 (2), 286-292, 2005 | 326 | 2005 |
| Magnesium and affective disorders H Murck Nutritional neuroscience 5 (6), 375-389, 2002 | 224 | 2002 |
| A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder M Fava, J Alpert, AA Nierenberg, D Mischoulon, MW Otto, J Zajecka, ... Journal of clinical psychopharmacology 25 (5), 441-447, 2005 | 215 | 2005 |
| Magnesium-deficient diet alters depression-and anxiety-related behavior in mice—influence of desipramine and Hypericum perforatum extract N Singewald, C Sinner, A Hetzenauer, SB Sartori, H Murck Neuropharmacology 47 (8), 1189-1197, 2004 | 208 | 2004 |
| Clinical and neurobiological effects of tianeptine and paroxetine in major depression T Nickel, A Sonntag, J Schill, AW Zobel, N Ackl, A Brunnauer, H Murck, ... Journal of clinical psychopharmacology 23 (2), 155-168, 2003 | 207 | 2003 |
| Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans K Held, IA Antonijevic, H Künzel, M Uhr, TC Wetter, IC Golly, A Steiger, ... Pharmacopsychiatry 35 (04), 135-143, 2002 | 193 | 2002 |
| Elevated nocturnal profiles of serum leptin in patients with depression IA Antonijevic, H Murck, RM Frieboes, R Horn, G Brabant, A Steiger Journal of psychiatric research 32 (6), 403-410, 1998 | 190 | 1998 |
| Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men IA Antonijevic, H Murck, S Bohlhalter, RM Frieboes, F Holsboer, A Steiger Neuropharmacology 39 (8), 1474-1481, 2000 | 184 | 2000 |
| The renin-angiotensin-aldosterone system in patients with depression compared to controls–a sleep endocrine study H Murck, K Held, M Ziegenbein, H Künzel, K Koch, A Steiger BMC psychiatry 3, 1-9, 2003 | 161 | 2003 |
| Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man RM Frieboes, H Murck, P Maier, T Schier, F Holsboer, A Steiger Neuroendocrinology 61 (5), 584-589, 1995 | 152 | 1995 |
| Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression K Held, H Künzel, M Ising, DA Schmid, A Zobel, H Murck, F Holsboer, ... Journal of psychiatric research 38 (2), 129-136, 2004 | 151 | 2004 |
| Treatment for severe melancholic depression M Manku, H Murck US Patent App. 11/066,329, 2006 | 146 | 2006 |
| New paradigms for treatment‐resistant depression C Zarate, RS Duman, G Liu, S Sartori, J Quiroz, H Murck Annals of the New York Academy of sciences 1292 (1), 21-31, 2013 | 139 | 2013 |
| St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial HP Volz, H Murck, S Kasper, HJ Möller Psychopharmacology 164, 294-300, 2002 | 133 | 2002 |
| Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial T Müller, M Mannel, H Murck, VW Rahlfs Psychosomatic Medicine 66 (4), 538-547, 2004 | 130 | 2004 |
| Symptomatic protective action of glycyrrhizin (licorice) in COVID-19 infection? H Murck Frontiers in immunology 11, 549292, 2020 | 127 | 2020 |
| The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial R Emsley, DJH Niehaus, L Koen, PP Oosthuizen, HJ Turner, P Carey, ... Schizophrenia research 84 (1), 112-120, 2006 | 116 | 2006 |
| Effects of hormones on sleep A Steiger, IA Antonijevic, S Bohlhalter, RM Frieboes, E Friess, H Murck Hormone research 49 (3-4), 125-130, 1998 | 101 | 1998 |
| Ketamine, magnesium and major depression–from pharmacology to pathophysiology and back H Murck Journal of psychiatric research 47 (7), 955-965, 2013 | 94 | 2013 |
| On the gender differences in sleep-endocrine regulation in young normal humans IA Antonijevic, H Murck, RM Frieboes, F Holsboer, A Steiger Neuroendocrinology 70 (4), 280-287, 1999 | 91 | 1999 |
Dorothee AuerProfessor of Neuroimaging, University of Nottingham在 nottingham.ac.uk 的电子邮件经过验证
